InSitu Biologics
Biologics & Biosimilars · Health Care
Overview
InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™, a peripheral nerve block for extended post-surgical pain relief.
Funding and backers
Total raised
$5.2M
4 rounds on record
Latest round
$1.3M
Convertible Note · Aug 2026 · 3 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 10
New executive William Taylor, Executive Officer · SEC Form D
Aug 4
Raised a round Convertible Note $1.3M · SEC Form D
Nov 13, 2025
Raised a round Venture round $4M · SEC Form D
Dec 15, 2023
Took on debt financing $15M · SEC Form D
Jun 29, 2020
Took on debt financing $5M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Aug 2026 | $1.3M | — | SEC Form D |
| Venture round | Nov 2025 | $4M | — | SEC Form D |
| Debt Financing | Dec 2023 | $15M | — | SEC Form D |
| Debt Financing | Jun 2020 | $5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | InSitu Biologics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Daniel HalpernExecutive Officer, DirectorSEC Form D
Bill TaylorExecutive OfficerSEC Form D
Sandi KlemannExecutive OfficerSEC Form D
William TaylorExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Neurolieve Biosciences is developing NLV-01, a first-in-class, non-opioid biologic designed to silence neuropathic pain and trigger…
Extended-release RNA medicines that turn transient treatments into durable therapies for chronic disease. ScionxBio uses synthetic…
Attralus is focused on advancing new solutions for amyloidosis therapy. The team has deep experience in Amyloid research and therapeutic…
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
KLISBio® is advancing peripheral nerve repair, naturally, with SILKBridge®, the first-of-its-kind Biointegrative Nerve Guide bioengineered…
People
Daniel Halpern
Executive Officer, Director
Bill Taylor
Executive Officer
Sandi Klemann
Executive Officer
William Taylor
Executive Officer
Robert Wilson
Director
Greg Van Guilder
Director
Ivan Shaw
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Oakdale
United States
HQ
Hopkins
United States
Regional office
A distinguished Medical Advisory Board comprised of nationally recognized experts in anesthesiology, orthopedic surgery,
3510 Hopkins Place North, Building 4, Oakdale, MN 55128